Vijay Shreedhar, Chief Commercial Officer at Adamas Pharmaceuticals Inc (ADMS), sold 4,514 shares at $6.39 ($29K) on 2021-02-01, disclosed to the SEC on 2021-02-01.
Open-market sale of $29k ADMS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |